News

News

Bright Minds Updates Investors On Psychedelic Compound Drugs

      Bright Minds Biosciences Inc. (CSE:DRUG) (NASDAQ:DRUG) provided an update on its clinical programs, anticipated upcoming milestones, and strategic priorities

News

HYTN Begins Cultivating Psilocybin Mushrooms

      HYTN  Innovations Inc. (CSE: HYTN) reported that it has successfully initiated the cultivation of psilocybin mushrooms under its Dealer’s

1 138 139 140 161